|Bid||21.42 x 800|
|Ask||22.29 x 1000|
|Day's range||20.76 - 21.71|
|52-week range||16.65 - 57.22|
|Beta (5Y monthly)||1.74|
|PE ratio (TTM)||N/A|
|Earnings date||09 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||47.82|
As you might know, Zogenix, Inc. (NASDAQ:ZGNX) recently reported its third-quarter numbers. Results overall were...
It is now my pleasure to introduce your host, Mr. Brian Ritchie of LifeSci Advisors. With me on today's call are Chief Executive Officer, Dr. Stephen Farr; Chief Commercial Officer, Ashish Sagrolikar; and Chief Financial Officer, Michael Smith.
Zogenix (ZGNX) delivered earnings and revenue surprises of -0.99% and 50.05%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?